Immunotherapy and Autoimmune Diseases
The Immunotherapy and Autoimmune Diseases Program is committed to finding the answers to today's most disabling and puzzling medical problems.
Stem cell therapy
DIAD pioneered and performed America’s first hematopoietic stem cell transplants to treat:
- Multiple sclerosis
- Crohn's disease
- Rheumatoid arthritis
- Chronic inflammatory demyelinating polyneuropathy (CIDP)
- Devic disease
- Myasthenia gravis
Our division is laboratory and clinic based, using methods that allow the safe isolation, manipulation and preservation of population of stem cells and immune cells for therapeutic purposes.
Currently DIAD collaborates with the divisions of Rheumatology, Nephrology, Gastroenterology and Hematology/Oncology, and the departments of Neurosciences and Transplant Surgery in innovation approaches and active protocols for the treatment of severe lupus, multiple sclerosis, rheumatoid arthritis and Crohn's disease.
We invite inquiries from physicians who would like to apply hematopoietic stem cells or immune cells toward innovative approaches to disease management and organ regeneration.
- Autoimmune Bullous Skin Disorders
- Crohn's Disease
- Intestinal Failure
- Multiple Sclerosis
- Myasthenia Gravis
- Rheumatoid Arthritis
- Sickle Cell
- Allogeneic Stem Cell Transplant
- Autologous Stem Cell Transplant
- Intestinal Stem Cell Transplant
- Hematopoietic Stem Cell Transplantation Program: Information about the Hematopoietic Stem Cell Transplantation Program at Northwestern Memorial Hospital.